Value proposition

Leading provider of peptide synthesis and bioanalytical tools for biotherapeutics, cell & gene therapies, and vaccines

Gyros Protein Technologies provides enabling peptide synthesis and immunoassay bioanalytical tools that help scientists increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioprocess applications.

With a large and growing installed base of instruments for nanoliter scale immunoassay automation (Gyrolab® xPand and Gyrolab xPloreTM), and peptide synthesis (PurePep® Chorus, Symphony® X and PurePep® Sonata®+) in the biopharmaceutical industry and related markets, the solutions from Gyros Protein Technologies accelerate discovery, development, and manufacturing of safer and more efficacious biotherapeutics, cell & gene therapies and vaccines. Gyros Protein Technologies is a division of Mesa Laboratories.

Immunoassays in the biotherapeutic workflow, peptide synthesis for academic and industrial applications, Biologics PK immunoassays, Host cell impurity immunoassays, Bioprocessing impurity immunoassays, Clinical PK immunoassays, Automated miniaturized ELISAs, and Cell & Gene Therapy